Fibrin degradation products in normal and abnormal pregnancy and parturition. - Wikidata - awgldk - TriplyDB

Fibrin degradation products in normal and abnormal pregnancy and parturition.

Fibrin degradation products in normal and abnormal pregnancy and parturition.

http://www.wikidata.org/entity/Q49197367

about

Clinical experience with brinase Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.Stroke in pregnant and postpartum women.Coagulation disorders An evaluation of the heat precipitation method for plasma fibrinogen estimation.Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity.Effect of intravenous prostaglandin E 2 on platelet function, coagulation, and fibrinolysis The effect of age on the fibrinolytic enzyme system.Pancreatitis, multiple infarcts and oral contraception.Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.Diffuse intravascular coagulation: an analysis of a basic mechanism of disease.Defining definitions: a Delphi study to develop a core outcome set for conditions of severe maternal morbidity.Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E The effect of oxygen on the fibrinolytic enzyme system in vivo.The origin of fibrin breakdown products and the interpretation of their appearance in the circulation Post-partum haemorrhage and tranexamic acid: a global issue.Haemostatic mechanism in the uterine circulation during placental separation.Assessment of coagulation and fibrinolysis in pre-eclampsia.Coagulation changes during termination of pregnancy by prostaglandins and by vacuum aspiration.

P2860

Q24564485-DAA7D3C4-3DB3-471D-917E-4B07BFAD8C5A Q33466813-965110C9-4A68-4007-A030-A56B160C5A4B Q34024469-F9DFECC7-535A-4590-B7FE-A99BC2682F9D Q34302763-D9DBD49A-D9C1-4C0A-907C-16B98F26B34C Q36632977-6F9E1603-87C6-4D05-8232-C26E78117023 Q36637755-63828410-76A0-4EA3-98DD-1D5E62EAB46A Q36649123-B71E4872-CFDD-42D9-9E9E-8487D9AECF90 Q36659895-76C1E267-E2DC-4653-BDEE-2FBE2FAF08A4 Q36811185-51552406-8645-4601-889A-200C1EBE68DE Q39636726-492AD19F-3A62-4051-AC7D-9FA9B8E48714 Q39953445-3AA30678-6693-40A2-89A9-46865CA08AED Q40103177-0B918B11-409F-410D-8D3E-2C0402209D56 Q41243699-6F4E43E7-C092-4DED-84A6-B7778E197EF7 Q41255291-FF1FD112-AAA5-4C5F-890C-625F8DF12306 Q41256664-A0473D7D-A246-44BC-9871-82FC349929D3 Q48273959-D55E8328-E770-43CE-ADCF-23A0FB50758A Q55128834-017E4C14-900D-4025-9774-4D9747FD5599 Q55441141-47BB72F8-20E4-4A6A-A685-944F2E6478CD Q55509780-FE1DF8B0-2570-42E4-9B23-223689FF71DF

P2860

Fibrin degradation products in normal and abnormal pregnancy and parturition.

http://www.wikidata.org/entity/Q49197367

description

1969 nî lūn-bûn

@nan

1969年の論文

@ja

1969年学术文章

@wuu

1969年学术文章

@zh

1969年学术文章

@zh-cn

1969年学术文章

@zh-hans

1969年学术文章

@zh-my

1969年学术文章

@zh-sg

1969年學術文章

@yue

1969年學術文章

@zh-hant

name

Fibrin degradation products in normal and abnormal pregnancy and parturition.

@en

Fibrin degradation products in normal and abnormal pregnancy and parturition.

@nl

type

label

Fibrin degradation products in normal and abnormal pregnancy and parturition.

@en

Fibrin degradation products in normal and abnormal pregnancy and parturition.

@nl

prefLabel

Fibrin degradation products in normal and abnormal pregnancy and parturition.

@en

Fibrin degradation products in normal and abnormal pregnancy and parturition.

@nl

P1433

Q49197367-56EF6529-7741-4A81-8CF3-03B5CBA76A11

P1476

Q49197367-44D4DD4F-284E-493F-B101-5E882EB3A092

P2093

Q49197367-447E0E64-5179-4709-B808-2179233708CD

Q49197367-6F417340-4B6B-4234-AA39-F8E66CF83469

Q49197367-728BB696-CFD5-44F0-A3FB-198EBEAF8306

Q49197367-825C03F4-4EAF-4DE5-AC31-65822E35947B

Q49197367-BCCA1D59-C58F-4B7C-96BF-B6D5336E11DE

P2860

Q49197367-2A6577EA-1DF6-4156-9926-8048ED9FC848

Q49197367-4A672B2E-B05B-4692-96EA-521C3ADF5184

Q49197367-4F4952B4-5106-411D-A5D8-80898360D665

Q49197367-DF8D032F-E9F7-431D-B7E7-C56F64AB326B

P304

Q49197367-F2A246B4-2C5E-427D-8D19-3248CBE4EC65

P31

Q49197367-6D6957D8-564E-4CBF-8E42-CA22A7E82927

P356

Q49197367-568BE70E-6013-477D-9667-A73B7A625B2B

P407

Q49197367-76523490-DBF7-449C-B7CF-A2AFC0C769A8

P433

Q49197367-4F5FAF14-B8D5-45AD-9537-BA759726BE15

P478

Q49197367-11C6D847-494B-4E3F-B01F-49CFA496DA57

P577

Q49197367-6C424EE5-80A0-453B-946C-F6B16F002435

P5875

Q49197367-39062F31-D291-408A-8B64-FD198E49DEFF

P698

Q49197367-13BE3476-7846-42BF-A803-6F5D6CDE2BC2

P921

Q49197367-61D80DD5-4CE2-4A8A-87E7-79CE5A67F587

P932

Q49197367-CF293511-DCF6-49E4-A016-64B2557B9F27

P356

P1433

P1476

Fibrin degradation products in normal and abnormal pregnancy and parturition.

@en

P2093

Bonnar J

http://www.w3.org/2001/XMLSchema#string

Davidson JF

http://www.w3.org/2001/XMLSchema#string

Douglas AS

http://www.w3.org/2001/XMLSchema#string

McNicol GP

http://www.w3.org/2001/XMLSchema#string

Pidgeon CF

http://www.w3.org/2001/XMLSchema#string

P2860

Fibrinolytic components of human uterine arterial and venous blood.

Significance of placental pathology in transplacental haemorrhage.

Studies of fibrinogen and other hemostatic factors in women with intrauterine death and delayed delivery.

Intravascular defibrination in pregnancy with associated pituitary and kidney damage.

P304

137-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.3.5663.137

http://www.w3.org/2001/XMLSchema#string

P407

P433

5663

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

1969-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

17863261

http://www.w3.org/2001/XMLSchema#string

P698

5306093

http://www.w3.org/2001/XMLSchema#string

P921

fibrin degradation product

P932

1983920

http://www.w3.org/2001/XMLSchema#string